Executive Summary
This digest covers 10 contract option exercises totaling $1.85B, with only 1 defense-related award (10% of total), reflecting a heavily civilian-skewed procurement stream. The dominant theme is civilian agency IT and R&D services, led by a $452M GSA FEDSIM award to MANTECH and a $322M Department of State construction contract to CADDELL.
The highest-conviction signal is a $133.5M firm-fixed-price award to PARTNER THERAPEUTICS for Leukine, a pharmaceutical product, which offers strong near-term revenue visibility for this private company. Key risks include execution risk on fixed-price contracts (CADDELL, PERATON, MAXIMUS) and the absence of defense-related awards, which limits exposure to NDAA-prioritized spending. Investors should watch for follow-on awards from GSA FEDSIM and IRS IT modernization as indicators of civilian agency budget stability.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Contract Option Exercises digest from June 05, 2026.
Investment Signals (4)
- PARTNER THERAPEUTICS wins $133.5M firm-fixed-price Leukine contract from HHS (HIGH)▲
This small business won a $133.5M firm-fixed-price delivery order from HHS/ASPR for Leukine, a pharmaceutical preparation, with $83.5M already outlaid. The fixed-price structure offers margin upside if costs are controlled, and the full-and-open competition win signals competitive strength against larger pharma firms.
- MANTECH's $452M GSA FEDSIM R&D contract provides multi-year revenue visibility (HIGH)▲
MANTECH secured a $452M cost-plus-fixed-fee contract through 2027, representing ~$60.3M annual revenue. The full-and-open competition win against other large primes signals strong competitive positioning in government R&D services.
- MAXIMUS wins $92.3M IRS IT modernization BPA call (MEDIUM)▲
MAXIMUS FEDERAL SERVICES secured a 5-year firm-fixed-price contract from the IRS for integrated IT systems, with $30.6M outlayed so far. This strengthens MAXIMUS's position in federal IT services, though fixed-price risk and phased funding require monitoring.
- CADDELL's $322M fixed-price State Department consulate contract carries execution risk (HIGH)▲
CADDELL CONSTRUCTION won a $322.4M firm-fixed-price contract for the Rio New Consulate Compound. Fixed-price construction contracts of this magnitude carry significant cost overrun risk, especially for a non-small business with no set-aside protection.
Risk Flags (4)
- Execution [HIGH RISK]▼
CADDELL CONSTRUCTION's $322M firm-fixed-price contract for the Rio consulate compound carries substantial cost overrun risk. Construction projects of this scale often face unforeseen site conditions, labor issues, or material cost inflation that could erode margins.
- Execution [MEDIUM RISK]▼
PERATON ENTERPRISE SOLUTIONS' $121.6M firm-fixed-price BPA call for IT application development carries fixed-price execution risk. While IT labor services are typically lower-risk, the negative outlayed amount (-$5,924) suggests minor accounting issues that could signal broader problems.
- Concentration [HIGH RISK]▼
The digest is heavily concentrated in civilian agencies (9 of 10 contracts), with only 1 defense-related award. This limits exposure to NDAA-prioritized spending and makes the portfolio more vulnerable to civilian budget cuts or continuing resolution impacts.
- Budget [MEDIUM RISK]▼
MAXIMUS's $92.3M IRS contract has only $30.6M outlayed (33% of total obligation), indicating phased funding. IRS budget constraints or political shifts could delay or reduce future funding tranches, impacting MAXIMUS's revenue recognition.
Opportunities (3)
- ◆
MANTECH's $452M GSA FEDSIM win signals strong demand for R&D services across civilian agencies. Investors should watch for follow-on FEDSIM awards that could indicate market share expansion for MANTECH or competitors like SAIC.
- ◆
With only 1 defense-related award in this digest, there is a potential opportunity for defense-focused contractors to capture market share as NDAA priorities drive spending. The absence of defense awards suggests a gap that could be filled by companies like L3HARRIS or NORTHROP GRUMMAN.
- ◆
JAG KETCHIKAN's $99.6M NOAA ship modernization contract provides a clear revenue stream for this small business. If executed well, this could position JAG KETCHIKAN for follow-on NOAA vessel work, though the company is private and not directly investable.
Sector Themes (3)
- ◆
Multiple contracts (MANTECH $452M, SAIC $290.8M, PERATON $121.6M, MAXIMUS $92.3M) demonstrate sustained civilian agency investment in IT and R&D services. This trend is driven by legacy system modernization needs and digital transformation mandates.
- ◆
Three HHS contracts (PARTNER THERAPEUTICS $133.5M, CTIS $85.6M, ABT GLOBAL $83.8M) totaling $302.9M highlight continued government investment in pharmaceutical preparedness, cancer research IT, and basic research. This is a bipartisan priority area.
- ◆
Five of the 10 contracts (CADDELL $322M, PARTNER THERAPEUTICS $133.5M, PERATON $121.6M, JAG KETCHIKAN $99.6M, MAXIMUS $92.3M) are firm-fixed-price, representing $769.5M or 42% of total obligation. This shifts cost overrun risk to contractors.
Watch List (5)
- 👁
{"entity"=>"MANTECH INTERNATIONAL CORPORATION", "reason"=>"Won the highest-value contract ($452M) in this digest, providing multi-year revenue visibility. Key to watch for market share trends in GSA FEDSIM R&D awards.", "trigger"=>"GSA FEDSIM subsequent R&D awards; quarterly filings for revenue contribution from this task order"}
- 👁
{"entity"=>"MAXIMUS FEDERAL SERVICES, INC.", "reason"=>"Secured $92.3M IRS IT contract with only 33% outlayed. Execution pace and option exercises will determine full contract value realization.", "trigger"=>"Quarterly outlayed amount vs. total obligation; IRS IT budget trends; option exercise announcements"}
- 👁
{"entity"=>"CADDELL CONSTRUCTION CO. (DE), LLC", "reason"=>"Carries significant execution risk on $322M fixed-price consulate contract. Cost overruns could materially impact margins.", "trigger"=>"Quarterly earnings for cost overrun disclosures; contract modifications or change orders"}
- 👁
{"entity"=>"PARTNER THERAPEUTICS, INC.", "reason"=>"Private company with $133.5M Leukine contract. Any IPO or acquisition would create a public investment vehicle.", "trigger"=>"IPO filings; acquisition announcements; HHS/ASPR follow-on procurement for Leukine"}
- 👁
{"entity"=>"JAG KETCHIKAN, LLC", "reason"=>"Small business with $99.6M NOAA ship modernization contract. Execution success could lead to follow-on awards.", "trigger"=>"NOAA future ship modernization solicitations; contract performance milestones"}
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 10 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Contract Option Exercises
🇺🇸 More from United States
View all →June 05, 2026
US Pre-Market SEC Filings Roundup — June 05, 2026
US Pre-Market SEC Filings Roundup
June 05, 2026
S&P 500 Technology Sector SEC Filings — June 05, 2026
S&P 500 Technology Sector SEC Filings
June 05, 2026
Global High-Priority Regulatory Events — June 05, 2026
Global High-Priority Regulatory Events
June 05, 2026
DHS Homeland Security Contracts — June 05, 2026
DHS Homeland Security Contracts